Literature DB >> 7500092

Alzheimer's disease: a treatment in sight?

S Lovestone, R Howard.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7500092      PMCID： PMC1073749          DOI： 10.1136/jnnp.59.6.566

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  12 in total

1.  Tacrine (tetrahydroaminoacridine; THA) and lecithin in senile dementia of the Alzheimer type: a multicentre trial. Groupe Français d'Etude de la Tetrahydroaminoacridine.

Authors:  G Chatellier; L Lacomblez
Journal:  BMJ       Date:  1990-02-24

2.  Selective loss of central cholinergic neurons in Alzheimer's disease.

Authors:  P Davies; A J Maloney
Journal:  Lancet       Date:  1976-12-25       Impact factor: 79.321

3.  Alzheimer disease: evidence for selective loss of cholinergic neurons in the nucleus basalis.

Authors:  P J Whitehouse; D L Price; A W Clark; J T Coyle; M R DeLong
Journal:  Ann Neurol       Date:  1981-08       Impact factor: 10.422

4.  Alzheimer's disease: the burden of the illness in England.

Authors:  A Gray; P Fenn
Journal:  Health Trends       Date:  1993

5.  Tetrahydroaminoacridine-lecithin combination treatment in patients with intermediate-stage Alzheimer's disease. Results of a Canadian double-blind, crossover, multicenter study.

Authors:  S Gauthier; R Bouchard; A Lamontagne; P Bailey; H Bergman; J Ratner; Y Tesfaye; M Saint-Martin; Y Bacher; L Carrier
Journal:  N Engl J Med       Date:  1990-05-03       Impact factor: 91.245

6.  A double-blind, placebo-controlled multicenter study of tacrine for Alzheimer's disease. The Tacrine Collaborative Study Group.

Authors:  K L Davis; L J Thal; E R Gamzu; C S Davis; R F Woolson; S I Gracon; D A Drachman; L S Schneider; P J Whitehouse; T M Hoover
Journal:  N Engl J Med       Date:  1992-10-29       Impact factor: 91.245

7.  A controlled trial of tacrine in Alzheimer's disease. The Tacrine Study Group.

Authors:  M Farlow; S I Gracon; L A Hershey; K W Lewis; C H Sadowsky; J Dolan-Ureno
Journal:  JAMA       Date:  1992-11-11       Impact factor: 56.272

Review 8.  Idebenone. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in age-related cognitive disorders.

Authors:  J C Gillis; P Benefield; D McTavish
Journal:  Drugs Aging       Date:  1994-08       Impact factor: 3.923

9.  A 30-week randomized controlled trial of high-dose tacrine in patients with Alzheimer's disease. The Tacrine Study Group.

Authors:  M J Knapp; D S Knopman; P R Solomon; W W Pendlebury; C S Davis; S I Gracon
Journal:  JAMA       Date:  1994-04-06       Impact factor: 56.272

10.  Oral tetrahydroaminoacridine in long-term treatment of senile dementia, Alzheimer type.

Authors:  W K Summers; L V Majovski; G M Marsh; K Tachiki; A Kling
Journal:  N Engl J Med       Date:  1986-11-13       Impact factor: 91.245
View more
  6 in total

Review 1.  The cholinergic system in the pathophysiology and treatment of Alzheimer's disease.

Authors:  Harald Hampel; M-Marsel Mesulam; A Claudio Cuello; Martin R Farlow; Ezio Giacobini; George T Grossberg; Ara S Khachaturian; Andrea Vergallo; Enrica Cavedo; Peter J Snyder; Zaven S Khachaturian
Journal:  Brain       Date:  2018-07-01       Impact factor: 13.501

2.  Development of Alzheimer disease in old major depressive patients based upon their health status: A retrospective study in Taiwan.

Authors:  Ping Tao; Szu-Nian Yang; Yu-Chi Tung; Ming-Chin Yang
Journal:  Medicine (Baltimore)       Date:  2019-05       Impact factor: 1.817

3.  A Network Pharmacology Based Research on the Mechanism of Donepezil in Treating Alzheimer's Disease.

Authors:  Lihua Liu; Yingying Zhu; Peng Fu; Jundong Yang
Journal:  Front Aging Neurosci       Date:  2022-04-08       Impact factor: 5.750

Review 4.  Synaptic Secretion and Beyond: Targeting Synapse and Neurotransmitters to Treat Neurodegenerative Diseases.

Authors:  Ziqing Wei; Mingze Wei; Xiaoyu Yang; Yuming Xu; Siqi Gao; Kaidi Ren
Journal:  Oxid Med Cell Longev       Date:  2022-07-25       Impact factor: 7.310

Review 5.  Neurodegenerative Diseases: Regenerative Mechanisms and Novel Therapeutic Approaches.

Authors:  Rashad Hussain; Hira Zubair; Sarah Pursell; Muhammad Shahab
Journal:  Brain Sci       Date:  2018-09-15

6.  Medial septum tau accumulation induces spatial memory deficit via disrupting medial septum-hippocampus cholinergic pathway.

Authors:  Dongqin Wu; Di Gao; Haitao Yu; Guilin Pi; Rui Xiong; Huiyang Lei; Xin Wang; Enjie Liu; Jinwang Ye; Huilin Yu; Yang Gao; Ting He; Tao Jiang; Fei Sun; Jingfen Su; Guoda Song; Wenju Peng; Ying Yang; Jian-Zhi Wang
Journal:  Clin Transl Med       Date:  2021-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.